Revolution Medici…
USUSDRevolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Počet burz, na kterých se obchodují akcie společnosti: 1. Na této stránce — cena a graf, dividendy, největší akcionáři a historie počtu akcií.
O Společnosti
- Web
- revmed.com
- Vztahy s Investory
- revmed.com/investors/
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sídlo
- REDWOOD CITY, United States
- Generální Ředitel
- Mark A. Goldsmith
- Zaměstnanci
- 883
- Založena
- 2014
- Akcie v Oběhu
- 214.34 mil. k 2026-07-31
- Volně Obchodovatelné Akcie
- 184.5 mil.
- Tržní Kapitalizace
- 43.24 mld. USD
- Insideři
- 1.85%
- Instituce
- 101.01%
- Odvětví (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US76155X1000
- LEI
- 549300JU3X0LBCQ65892
- P/E
- ztráta
- FCF
- −1.23 mld. USD
- Dluh
- ?
- Zisky a FCF — za 12 měsíců do roku 30.06.2026 (nejnovější zpráva společnosti).
- NAV
Popis
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Burzy a Tickery
| Burza | Ticker | Měna | Cena | Typ |
|---|---|---|---|---|
| US USA Stocks | RVMD | USD | 189.26 -2.20% | kmenové akcie |
Největší Držitelé
| Držitel | Podíl | Akcie | Datum Zprávy |
|---|---|---|---|
| Blackrock Inc. | 6.39% | 13.7 mil. | 2026-06-30 |
| Farallon Capital Managem… | 6.32% | 13.55 mil. | 2026-06-30 |
| FMR, LLC | 5.69% | 12.2 mil. | 2026-06-30 |
| Baker Bros. Advisors, LP | 5.34% | 11.44 mil. | 2026-06-30 |
| Jupiter Topco LLC | 5.01% | 10.74 mil. | 2026-06-30 |
| Darwin Global Management… | 4.96% | 10.63 mil. | 2026-06-30 |
| Vanguard Capital Managem… | 4.24% | 9.09 mil. | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.87% | 8.29 mil. | 2026-06-30 |
| Nextech Invest, Ltd. | 3.55% | 7.6 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.99% | 6.41 mil. | 2026-06-30 |
| Paradigm Biocapital Advi… | 2.97% | 6.36 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.16% | 4.63 mil. | 2026-06-30 |
| Growth Fund of America | 1.38% | 2.96 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.25% | 2.67 mil. | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.15% | 2.47 mil. | 2026-07-31 |
| BORISY ALEXIS (Director) | ≈1.09% | 2.34 mil. | 2026-06-18 |
| VANGUARD INDEX FUNDS-Van… | 1.07% | 2.29 mil. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.84 mil. | 2026-04-30 |
| iShares Trust-iShares Bi… | 0.65% | 1.39 mil. | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 0.54% | 1.17 mil. | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.51% | 1.1 mil. | 2026-07-31 |
| GOLDSMITH MARK A (Chief… | ≈0.46% | 984 238 | 2026-08-21 |
| KELSEY STEPHEN MICHAEL (… | ≈0.14% | 291 876 | 2026-09-11 |
| HORN MARGARET A (Chief O… | ≈0.07% | 154 647 | 2026-06-17 |
| ANDERS JACK LEE (Chief F… | ≈0.06% | 123 269 | 2026-06-24 |
| WANG XIAOLIN (Officer) | ≈0.05% | 116 063 | 2026-03-17 |
| LIN WEI (Officer) | ≈0.05% | 101 366 | 2026-03-17 |
| HORNING SANDRA (Director… | ≈0.05% | 97 765 | 2026-06-18 |
| CISLINI JEFFREY TODD (Ge… | ≈0.03% | 55 907 | 2026-08-21 |
| SCHROEDER THILO (Directo… | — | — | 2024-12-05 |
Přihlaste se Google